Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:15 PM
Ignite Modification Date:
2025-12-24 @ 11:15 PM
NCT ID:
NCT02826356
Eligibility Criteria:
Inclusion Criteria:
* Every patient followed for the first time in our reference center for severe confirmed ACE-I or ARB-induced angioedema. Data were analyzed from patients attended either in a specialized angioedema consultation or during a hospitalization in our intensive care unit.
* Severe attack was defined either by its localization over the shoulder or by an severe abdominal attack.
Exclusion Criteria:
\- Patients which received no specific treatment (icatibant, C1-inhibitor concentrate) were excluded.
Healthy Volunteers:
False
Minimum Age:
18 Years
Study:
NCT02826356
Study Brief:
Protocol Section:
NCT02826356